Then, suddenly, the NIH paused the trial ... The source claimed to have information, via Dr. Schrag, about the drug company Cassava Sciences, which was under investigation for allegedly ...
She was also involved in ChartRequest, a release of information company, and played a crucial role as the second ... She is currently the PI for the NIH-funded Sight-Saving Engagement and Evaluation ...
The National Institutes of Health (NIH) on Friday made a significant reduction in grants reserved for research institutions, a decision that may significantly impact American higher education.
The No. 2 in command at the National Institutes of Health (NIH), Dr. Lawrence A ... and faced criticism for slow-rolling the release of information requested by Republican investigators for ...
We will get back in touch with you when we have further information. Thank you for your service to NIH.” Some of the canceled meetings include study sections, which review the applications for ...
2025 may continue if it does not involve public release of information,” may also advance. NIH researchers can continue to submit their papers and abstracts for studies that began before Trump ...
I am a cancer researcher and a cancer survivor. A few nights ago, I came across a post on X by @NIH that (seemingly) proudly announced massive cuts to the indirect cost rate on all current and future ...
and take that basic science information and do engineering and turn it into things you can sell and treat diseases with.” How will the new NIH policy affect research? Without the funding to ...
Dr. Mehmet Oz, nominated to run the Centers for Medicare & Medicaid Services, will sell shares in Eli Lilly and UnitedHealth.
The NIH is led by one agency director and five deputies. With Lauer’s departure, two of those deputies have left in as many days, and the agency is currently being led by an acting director ...
Faden is the founder of the Berman Institute of Bioethics and the Philip Franklin ... A policy from the NIH, drafted years ago, is clear about this. Any early stoppage of a clinical trial requires ...